Quick answers
- What is Escitalopram used for?
- The FDA-approved label (Lexapro, Allergan, Inc., October 1, 2023) says: “Lexapro is indicated for the treatment of: • major depressive disorder (MDD) in adults and pediatric patients 12 years of age and older. • generalized anxiety disorder (GAD) in adults and pediatric patients 7 years of age and older. Lexapro is a selective serotonin reuptake inhibitor (SSRI) indicated for the …” This page is not medical advice. Talk to your doctor or pharmacist before you start, stop or change any medicine.
- Does Escitalopram have a boxed warning?
- Yes. The FDA label for Lexapro has a boxed warning (“WARNING: SUICIDAL THOUGHTS AND BEHAVIORS”), the FDA’s strongest warning. Read it on the full label and ask your pharmacist.
- Is there a shortage of Escitalopram?
- No current shortage is listed by the FDA for the products of this medicine (FDA data from October 30, 2026).
- Has Escitalopram been recalled?
- FDA enforcement reports list 1 recall of products of this medicine; the newest started March 24, 2016 (Class III). A recall usually concerns specific lots, not every product.
- Who makes Escitalopram?
- 42 companies list prescription products of Escitalopram in the FDA NDC Directory, including Bryant Ranch Prepack, A-S Medication Solutions and Northwind Health Company, LLC.
What Escitalopram is used for
Quoted from the “Indications and Usage” section of the FDA-approved label.
Lexapro is indicated for the treatment of: • major depressive disorder (MDD) in adults and pediatric patients 12 years of age and older. • generalized anxiety disorder (GAD) in adults and pediatric patients 7 years of age and older. Lexapro is a selective serotonin reuptake inhibitor (SSRI) indicated for the …
— FDA label: Lexapro, Allergan, Inc., effective October 1, 2023. Read the full label on DailyMed →
The FDA has 107 labels for products of this medicine (different makers and forms); uses can differ between them. Check the label that comes with your own medicine.
This page is not medical advice. Talk to your doctor or pharmacist before you start, stop or change any medicine.
Conditions named on the label
These condition names appear word for word in the label’s “Indications and Usage” text (matched with a reviewed table). Each page lists hospitals whose own websites name the condition.
Related medical specialties
Boxed warning
A boxed warning (“black box”) is the FDA’s strongest warning on a drug label, for serious or life-threatening risks.
This label has a boxed warning. Its heading: WARNING: SUICIDAL THOUGHTS AND BEHAVIORS
. Read it on the full label →
107 of 107 FDA labels for this medicine have a boxed warning.
Forms and how it is given
| Dosage forms | Tablet, film coated · Tablet · Solution · Capsule |
|---|---|
| Route | Oral |
| Prescription products | 155 in the FDA NDC Directory |
| Brand names | Lexapro |
What pharmacies pay (NADAC)
The National Average Drug Acquisition Cost (NADAC) is the average price U.S. retail pharmacies paid to buy one unit of a medicine (one tablet, one mL or one gram), from a monthly survey of pharmacy invoices by the Centers for Medicare & Medicaid Services (CMS). State Medicaid programs use it to pay pharmacies.
This is not the price you pay. What you pay depends on your insurance (copay or coinsurance), your pharmacy and any discounts, and pharmacies also charge for filling a prescription. Ask your pharmacist or your health plan what your price will be.
| Strength and form | Generic or brand | Pharmacies pay |
|---|---|---|
| escitalopram oxalate 10 mg tablet | Generic | $0.0391 per tablet |
| escitalopram oxalate 10 mg tablet, film coated | Generic | $0.0391 per tablet |
| escitalopram oxalate 10 mg tablet, film coated | Brand: Lexapro | $15.43 per tablet |
| escitalopram oxalate 10 mg/21 tablet, film coated | Generic | $0.0391 per tablet |
| escitalopram oxalate 15 mg capsule | Generic | $5.51 per capsule |
| escitalopram oxalate 20 mg tablet | Generic | $0.0632 per tablet |
| escitalopram oxalate 20 mg tablet, film coated | Generic | $0.0632 per tablet |
| escitalopram oxalate 20 mg tablet, film coated | Brand: Lexapro | $16.11 per tablet |
| escitalopram oxalate 20 mg/21 tablet, film coated | Generic | $0.0632 per tablet |
| escitalopram oxalate 5 mg tablet | Generic | $0.0429 per tablet |
| escitalopram oxalate 5 mg tablet, film coated | Generic | $0.0429 per tablet |
| escitalopram oxalate 5 mg tablet, film coated | Brand: Lexapro | $14.74 per tablet |
| escitalopram oxalate 5 mg/5 mL solution | Generic | $0.1608 per mL |
NADAC list of November 4, 2026; these prices took effect between January 2, 2026 and October 21, 2026. Shown only where a package’s NDC code matches the NADAC list exactly, and only for that exact strength and form: nothing is averaged across strengths. Strengths and forms not listed here have no NADAC price.
Source: NADAC (National Average Drug Acquisition Cost) 2026, data.medicaid.gov (CMS) →
Companies that list this medicine
Labelers in the FDA NDC Directory: the company named on the package (maker or distributor), with the number of prescription products.
- Bryant Ranch Prepack17 products
- A-S Medication Solutions12 products
- Northwind Health Company, LLC8 products
- Remedyrepack Inc.8 products
- Proficient Rx LP7 products
- Preferred Pharmaceuticals Inc.5 products
- PD-Rx Pharmaceuticals, Inc.4 products
- Macleods Pharmaceuticals Limited4 products
- Direct_Rx4 products
- Rising Pharma Holdings, Inc.4 products
- Amneal Pharmaceuticals LLC4 products
- Aurobindo Pharma Limited4 products
- Quallent Pharmaceuticals Health LLC3 products
- Torrent Pharmaceuticals Limited3 products
- QPharma, Inc.3 products
- Solco Healthcare US, LLC3 products
- Amneal Pharmaceuticals of New York LLC3 products
- Coupler LLC3 products
- Asclemed USA, Inc.3 products
- Ascent Pharmaceuticals Inc3 products
- St. Mary's Medical Park Pharmacy3 products
- BluePoint Laboratories3 products
- Exelan Pharmaceuticals Inc.3 products
- NCS HealthCare of KY, LLC dba Vangard Labs3 products
- American Health Packaging3 products
- Jubilant Cadista Pharmaceuticals Inc.3 products
- Cipla USA Inc.3 products
- Accord Healthcare Inc.3 products
- NuCare Pharmaceuticals, Inc.3 products
- Allergan, Inc.3 products
- Aphena Pharma Solutions - Tennessee, LLC3 products
- NorthStar RxLLC3 products
- Cardinal Health 107, LLC2 products
- Advanced Rx Pharmacy of Tennessee, LLC2 products
- Major Pharmaceuticals2 products
- Legacy Pharmaceutical Packaging, LLC2 products
- Camber Pharmaceuticals, Inc.1 product
- RedPharm Drug, Inc.1 product
- Almatica Pharma LLC1 product
- Lupin Pharmaceuticals, Inc.1 product
- Chartwell Governmental & Specialty RX, LLC.1 product
- Chartwell RX, LLC1 product
FDA approval history
- NDA: New Drug Application: how a new (usually brand-name) medicine is approved.
- ANDA: Abbreviated New Drug Application: how a generic version is approved.
| Application | Sponsor | Approved | Later changes approved |
|---|---|---|---|
| NDA021323 LEXAPRO | Abbvie | August 14, 2002 | 29, latest April 19, 2024 2024: Labeling · 2023: Labeling · 2023: Efficacy |
| NDA219130 ESCITALOPRAM | Almatica | August 29, 2025 | — |
Generic approvals (16)
- ANDA202227Amneal Pharms · March 14, 2012
- ANDA079062Aurobindo Pharma Ltd · April 2, 2012
- ANDA202221Hetero Labs Ltd III · June 12, 2012
- ANDA078169Chartwell Rx · September 11, 2012
- ANDA078604Invagen Pharms · September 11, 2012
- ANDA078777Graviti Pharms · September 11, 2012
- ANDA090432Aurobindo Pharma Ltd · September 11, 2012
- ANDA090939Torrent Pharms Ltd · September 11, 2012
- ANDA202210Macleods Pharms Ltd · September 11, 2012
- ANDA202389Accord Hlthcare · September 11, 2012
- ANDA202280Jubilant Cadista · September 12, 2012
- ANDA090477Chartwell Molecular · June 12, 2013
- ANDA078032Prinston Inc · August 28, 2015
- ANDA202754Macleods Pharms Ltd · March 31, 2016
- ANDA205619Amneal Pharms · May 17, 2017
- ANDA215177Ascent Pharms Inc · July 15, 2025
Shortage status
The FDA drug shortage list does not show these products.
Recalls
From FDA enforcement reports, matched by the product’s NDC code. A recall usually covers specific lots only: check the lot number on your package and ask your pharmacist. Do not stop a medicine on your own.
-
March 24, 2016 · Class III · Terminated · D-1516-201
Labeling: Incorrect or Missing Lot and/or Expiration Date
Escitalopram Tablets USP 20 mg, 100-count bottles, Rx Only, Manufactured for: Lupin Pharmaceuticals, Baltimore, MD, 21202, Manufactured by: Lupin Limited, Goa 403 722, India, NDC 68180-136-01 — Lupin Limited
What do the recall classes mean?
Class I: The most serious type: there is a reasonable chance that using the product will cause serious health problems or death.
Class II: Using the product may cause temporary or medically reversible health problems, or the chance of serious problems is remote.
Class III: Using the product is not likely to cause health problems (for example a labeling or packaging issue).
Official identifiers
Sources
- FDA-approved label on DailyMed (National Library of Medicine) — Lexapro, Allergan, Inc., effective October 1, 2023; via openFDA, FDA data exported October 30, 2026, retrieved October 31, 2026
- NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 27, 2026, retrieved October 31, 2026
- Drug shortages (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
openFDA data is provided by the FDA as is; it may be incomplete. Always rely on the label that comes with your medicine. FDA Enforcement Report search →